¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Poisoning by agents primarily affecting the cardiovascular system"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • self-system
    ÀÚ±âü°è
  • skeletal system
    »À´ë°èÅë, °ñ°Ý°è
  • social security system
    »çȸº¸ÀåÁ¦µµ
  • urinary system
    ºñ´¢°èÅë, ºñ´¢°è
  • urogenital system
    ºñ´¢»ý½Ä±â°èÅë, ºñ´¢»ý½Ä±â°è
  • vascular system
    Ç÷°ü°èÅë, Ç÷°ü°è
  • vegetative nervous system
    ½Ä¹°½Å°æ°èÅë, ½Ä¹°½Å°æ°è
  • value system
    °¡Ä¡Ã¼°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • scavenging system
    ¸¶Ãë°¡½ºÁ¦°Åü°è
  • skeletal system
    »À´ë°èÅë
  • social security system
    »çȸº¸ÀåÁ¦µµ
  • somatosensory system
    ¸ö°¨°¢°èÅë
  • sound conduction system
    ¼Ò¸®Àü´Þ°èÅë, ÀüÀ½°è
  • static system
    Á¤Áö°è
  • stereotactic system
    Á¤À§°íÁ¤±â
  • subcortical descending system
    °ÑÁú¹ØÇÏÇà°è, °ÑÁú¹Ø³»¸²°èÅë
  • superficial musculo-aponeurotic system
    ¾ó±¼³ÎÈûÁÙ°èÅë
  • to and fro absorbent system
    ¿Õº¹Èí¼ö½Äȸ·Î
  • transdermal drug delivery system
    °æÇǾ๰Àü´Þü°è
  • urinary system
    ºñ´¢°èÅë
  • urogenital system
    ºñ´¢»ý½Ä°èÅë
  • value system
    °¡Ä¡Ã¼°è
  • vascular system
    Ç÷°ü°èÅë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • hypothalamohypophyseal portal system
    ½Ã»óÇϺγúÇϼöü¹®¸Æ°è.
  • hypothalamohypophyseal system
    ½Ã»óÇϺγúÇϼöü°è.
  • hypothalamopituitary system
    ½Ã»óÇϺγúÇϼöü°è.
  • hypothalamus pituaitary system
    ½Ã»óÇϺγúÇϼöü°è.
  • imitation gold of brass system
    Ȳµ¿°è¸ðÁ¶±Ý(üÜÔÞͧټðãÐÝ).
  • immersion system
    ¾×ħ°è(äûöÙͧ).
  • immobilization system
    °íÁ¤¹æ½Ä
  • immune system
    ¸é¿ª°è.
  • immune system
    ¸é¿ª°è(Øóæ¹Í§)
  • immunologic system
    ¸é¿ª°è.
  • impulse conducting system
    ÈïºÐÆÄÀüµµ°è.
  • impulse conduction system
    ÈïºÐÆÄÀüµµ°è.
  • impulse conduction system
    ÈïºÐÆÄÀüµµ°è(ýéÝÇ÷îîîÓôͧ).
  • inference system
    ÃßÃø°è
  • infusion-aspiration system
    ÁÖÀÔÈíÀÔÀåÄ¡
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • radium poisoning
    ¶óµãÁßµ¶(¡­ñéÔ¸).
  • radium poisoning
    ¶óµãÁßµ¶(¡­ñéÔ¸)
  • saturnine poisoning
    ³³Áßµ¶.
  • saturnine poisoning
    ³³Áßµ¶(¡­)
  • saturnism =lead poisoning, plumbism
    ³³Áßµ¶(Áõ).
  • saturnism =lead poisoning, plumbism
    ³³Áßµ¶(Áõ)(¡­ñø)
  • self inflicted poisoning
    ÀÚ±â°¡ÇØÁßµ¶(í»ÐùÊ¥úªñéÔ¸).
  • shellfish poisoning
    ÆÐ·ùÁßµ¶(Áõ) (¡­ñéÔ¸ñø).
  • shellfish poisoning
    ÆÐ·ùÁßµ¶(Áõ) (¡­ñéÔ¸ñø)
  • sodium chloride poisoning
    ¿°È­³ªÆ®·ýÁßµ¶Áõ(¡­ñéÔ¸ñø).
  • sodium chloride poisoning
    ¿°È­³ªÆ®·ýÁßµ¶Áõ(¡­ñéÔ¸ñø)
  • sponge poisoning
    ÇØ¸éÁßµ¶(Ì´ËÎÌ¡ËÄ).
  • staphylococcal food poisoning
    Æ÷µµ±¸±Õ½ÄÁßµ¶(¡­ãÝñéÔ¸).
  • stimulant poisoning
    ÀÚ±ØÁßµ¶
  • sublimate poisoning
    ½ÂÈ«Áßµ¶(ÊÙÌ¡ËÄ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
CVRD cardiovascular-renal disease
CVRR cardiovascular recovery room
CVT cardiovascular technologist; central venous temperature; congenital vertical talus
HASCVD hypertensive arteriosclerotic cardiovascular disease
HCVD hypertensive cardiovascular disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
CELSS Controlled Ecological Life Support System
CNCPS Cornell Net Carbohydrate and Protein System
DBMS Data Base Management System
DSS Decision Support System
EMS Emergency Medical System
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • non-specific arousal system
    ºñƯÀ̼º °¢¼º°è
  • occlusal system
    ÀÇÄ¡ ÀΰøÄ¡ ±³ÇÕ¸é ¹è¿­ ü°è
    ÀÇÄ¡¿¡¼­ ÀüÄ¡¿Í ±¸Ä¡ÀÇ °¢ Ä¡¾ÆÀÇ Çüųª µðÀÚÀÎ, ÀüüÀû ¹è¿­ µî.
  • oil immersion system
    À¯Ä§ ÀåÄ¡
  • open vessel system
    °³¹æ ¼øÈ¯°è
  • opiate sensitive system
    ¾ÆÆí¼º °¨¼º°è
  • opioid-mediated analgesia system
    ¾ÆÆí ¸Å°³ ÁøÅë°è
  • osseous system
    »À ±â°ü, °ñ°è
  • oxidation reduction system
    »êÈ­ ȯ¿ø°è
  • pain system
    µ¿Åë°è
  • pain transmission system
    µ¿Åë Àü´Þ°è
  • pain-modulating system
    µ¿Åë Á¶Àý°è
    ÁßÃß ½Å°æ°è´Â Åë°¢À» Àü´ÞÇÏ¿© ÅëÁõÀ» ´À³¢°Ô ÇÏ´Â ±â´É À̿ܿ¡µµ µ¿ÅëÀ» ÅëÁ¦ÇÏ´Â ÀÏ·ÃÀÇ ½Å°æ Á¶Á÷À» °®°í ÀÖÀ¸¸ç, ½Å°æ ¼¼Æ÷¿¡¼­ o
  • pallidal system
    ´ãⱸ°è
  • palm and sole system of identification
    ¼öÀå Á·Àú È®Àιý
  • peripheral nervous system
    ¸»ÃÊ ½Å°æ°è
    1. ³ú ½Å°æ, ô¼ö ½Å°æ, ÀÚÀ² ½Å°æ. 2. ³ú¿Í ô¼ö ¹Ù±ù¿¡ ÀÖ´Â ¿îµ¿ ¹× °¨°¢ÀÇ ±³°¨½Å°æ°ú ºÎ±³°¨½Å°æ.
  • peripheral pain sensory system
    ¸»Ãʼº Åë°¢°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
radiation-sensitizing agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
(12 Dec 1998)
vasoconstrictor agents Drugs used to cause constriction of the blood vessels.
(12 Dec 1998)
vasodilator agents Drugs used to cause dilation of the blood vessels.
(12 Dec 1998)
gastrointestinal agents Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.
(12 Dec 1998)
reducing agents Materials that add an electron to an element or compound, that is, decrease the positiveness of its valence.
(12 Dec 1998)
renal agents Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' clearance of other drugs, and for diagnosis of renal function.
(12 Dec 1998)
reproductive control agents Substances used either in the prevention or facilitation of pregnancy.
(12 Dec 1998)
glycine agents Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
(12 Dec 1998)
menstruation-inducing agents Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhoea is a secondary result.
(12 Dec 1998)
chelating agents Organic chemicals that form two or more coordination bonds with a central metal ion. Heterocyclic rings are formed with the central metal atom as part of the ring. Some biological systems form metal chelates, e.g., the iron-binding porphyrin group of haemoglobin and the magnesium-binding chlorophyll of plants. They are used chemically to remove ions from solutions, medicinally against microorganisms, to treat metal poisoning, and in chemotherapy protocols.
(12 Dec 1998)
chemical warfare agents Chemicals that are used to cause the disturbance, disease, or death of humans during war.
(12 Dec 1998)
riot control agents, chemical Chemical substances which are employed during a riot in order to control or disperse the rioting parties.
(12 Dec 1998)
cholinergic agents Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of acetylcholine, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of muscarinic agonist, although most modern texts discourage that usage.
(12 Dec 1998)
photosensitizing agents Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
(12 Dec 1998)
wetting agents A surfactant that renders a surface wettable by water or enhances the spreading of water over the surface; used in foods and cosmetics; important in contrast media; also with contact lenses, dentures, and some prostheses.
Synonym: humectants; hydrating agents.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á